Data compiled by Redley Lamar · ChainSifter Intelligence
1Suppliers
5Customers
3Debt Items
3Related Chains
Source-Backed Evidence Depth
China SXT Pharmaceuticals, Inc. (SXTC) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
10Total relationships
3Distinct source URLs
7High confidence
0.828Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Reciprocal relationship from LGCL graph: formance obligation to the corporate customers, we should bear the loss of the corporate customers for breach of contract on our own, and then independently c…
China SXT Pharmaceuticals, Inc. Customers
Ticker
Name
Confidence
Evidence
SUXUANTANG
SUXUANTANG
92%
Suxuantang had one significant customer which accounted for 68.72% of our total revenue during the year ended March 31, 2025.
DRUG-STORES
DRUG-STORES
90%
We currently manufacture 200 Regular TCMP products listed on China Pharmacopoeia (version 2020) Parts I and IV for hospitals and drug stores in treatment of various diseases or serving as dietary sup…
HOSPITALS
HOSPITALS
90%
We currently manufacture 200 Regular TCMP products listed on China Pharmacopoeia (version 2020) Parts I and IV for hospitals and drug stores in treatment of various diseases or serving as dietary sup…
JIUZHOUTONG-PHARMACEUTICAL-CO-LTD
JIUZHOUTONG-PHARMACEUTICAL-CO-LTD
62%
ugh the growing pipeline of new TCMP products. Our diverse portfolio of products and our new product pipelines include products for high-incidence and high-mortality conditions in the PRC, such as ca…
STREETERVILLE-CAPITAL-LLC
STREETERVILLE-CAPITAL-LLC
62%
NOTE 10 – BORROWINGS (CONTINUED) Long-term borrowings (Continued) Long-term bank loans are loans the Company borrowed from Jiangsu Taizhou Rural Commercial Bank which are valid from November 2, 2022 …
China SXT Pharmaceuticals, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
SXTC-DEBT-12847
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2025-03-31.
SXTC-DEBT
Debt stack $648,865
90%
Market cache reports total debt of $648,865.
SXTC-DEBT-12846
Warrants outstanding: 0.01
90%
xbrl warrant detail from xbrl 2023-09-30.
China SXT Pharmaceuticals, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for China SXT Pharmaceuticals, Inc..
China SXT Pharmaceuticals, Inc. Ownership
Holder
Name
Confidence
Evidence
SXTC-OWNER-CITADEL-ADVISORS-LLC
CITADEL ADVISORS LLC
90%
13F overlay lists CITADEL ADVISORS LLC as top holder; 8 tracked holders.
China SXT Pharmaceuticals, Inc. Extended Supply Chain Network
